tag:blogger.com,1999:blog-5574479.post417833912968995357..comments2024-03-29T06:53:23.405+00:00Comments on The IPKat: Hatching Europe's Unified Patent Court: who will pay for the chickens and eggs?Verónica RodrÃguez Arguijohttp://www.blogger.com/profile/05763207846940036921noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-5574479.post-57593824732159361782013-05-20T12:28:53.397+01:002013-05-20T12:28:53.397+01:00Who said big pharma wants this? I'd bet that t...Who said big pharma wants this? I'd bet that they are being advised to opt out their patents at the first possible opportunity. The flip side to big pharma - the generics - would no doubt welcome thw UPC with open arms but they have no money and no significant UK presence so HMG is unlikely to listen to them even if they do pipe up. Stasis awaits...Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-5574479.post-49278352413511073442013-05-20T09:13:22.226+01:002013-05-20T09:13:22.226+01:00Here (provocatively) are my predictions.
1. Germa...Here (provocatively) are my predictions.<br /><br />1. Germany will invest, for it already has 85% of all the patent litigation in the EU. It will train the judges in Budapest. It will set Munich up to do the litigation in English. Bifurcation can be finessed away under the UPC. Remember how Franz-Josef Strauss invested, to get the EPO for Munich. Its benefitr to the Munich economy is huge and ever bigger.<br /><br />2. France will invest. The Central Division is a huge international prestige public infrastructure project. The dynamic and super-intelligent enarchs will love it.<br /><br />3. But only chem/bio has the patents that are worth litigating under the UPC. So Big Pharma will ask HMG to hurry up.MaxDreinoreply@blogger.com